Selectively targeting mutant BRAF in thyroid cancer

J Clin Endocrinol Metab. 2010 Jan;95(1):60-1. doi: 10.1210/jc.2009-2332.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Papillary / drug therapy*
  • Drug Delivery Systems*
  • Humans
  • Mice
  • Mutant Proteins / antagonists & inhibitors
  • Mutation, Missense / physiology
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Substrate Specificity
  • Thyroid Neoplasms / drug therapy*
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Mutant Proteins
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf